Executives On The Move: Changes At Medivir, And More
Executive Summary
Magnus Christensen takes over as Medivir's interim CEO, while Yilmaz Mahshid joins the board. Meanwhile, bluebird bio appoints a new chief commercial officer for severe genetic disease and ARCA biopharma appoints a new CFO and VP of clinical development.